The shield used in the system had been cleared by the Food and Drug Administration (FDA) in June 2009 in an abbreviated process used for devices that are considered equivalent to products already on the market.
ICAD DIGITIZER SKIN
for early-stage breast cancer, endometrial cancer and skin cancer, as well as other varieties where radiation therapy is indicated, the initial report on the acquisition stated. It acquired Xoft's Axxent system which delivers radiation therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue, according to the company. In December 2010, iCAD expanded the company’s oncology footprint by acquiring Xoft, Inc. ICad originally focused on image-analysis products designed to help radiologists and other health-care providers detect cancers early.
These acquisitions brought together two of the three companies with FDA clearance to market CAD solutions for breast cancer in the United States. of Ohio and its subsidiary, CADx Systems, Inc. Subsequently, the company acquired Qualia Computing, Inc.
(ISSI) which had developed an approved computer-aided detection system for breast cancer.
The company acquired Intelligent Systems Software, Inc. In 2001, foreseeing a decline in the graphic arts and photo finishing industries, Howtek elected to focus solely on the medical imaging market.
ICAD DIGITIZER SERIES
From 1984 to 2000 Howtek successfully developed a series of products that improved the quality of digital imaging while reducing the price and complexity of digitizing systems. The scanners converted printed, photographic and other hard copy images to digital form for use in the graphic arts, photo finishing and medical industries. Howtek developed, manufactured and marketed digitizing systems or scanners. iCAD provides a range of CAD solutions for mammography and computed tomography for colorectal cancer. iCAD offers computer-aided detection (CAD) technologies, advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. The iCAD brand includes two distinct business units that provide tools for detection, diagnosis and treatment of cancers.
ICAD DIGITIZER SOFTWARE
TheĬompany believes its vertical integration of CAD and hardwareĭevelopment results in better integration of software and film digitizerĬomponents, lower production costs and reduced administrative overhead. Step in the CAD product design, production and assembly process. As such, iCAD is able to reduce costs at each Integrated digitizer hardware and CAD software company offering computerĪided detection solutions. ICAD engineers, develops, manufactures and markets computer aidedĭetection (CAD) products for the early detection of breast cancer and In interpretation of screening mammograms. Parr, "and we feel we have responded with a superior tool for use This is a feature our customers have requested," continued Physician in recognizing and addressing early indicators of breastĬancer. President & CEO, "it provides additional support to the Related to the pathology in question," said Scott Parr, iCAD's "Because ClearLook provides enhanced viewing and hard data System for early detection of breast cancer. The Clear Look package, available as an option for theĬompany's Second Look 500 Mammographic CAD systems, is alsoĪvailable as an option on iCAD's category-defining Second Look 300 Understand why a particular set of features was marked, or not marked, Suspicious features on a display screen typically located whereĬlearLook offers full-image high-resolution zoom capabilities toĪllow the radiologist to enlarge any area of the breast image presented.ĬlearLook provides the radiologist descriptive data related to massesĪnd calcifications in the region of interest, helping the radiologist Radiologist Review Station, which presents breast images marked to show (NASDAQ:ICAD) has debuted ClearLook CAD ImageĬharacterization Package.
ICAD DIGITIZER FREE
0 kommentar(er)
